-
XW0G Upper GI
-
XW0G0 Open
-
XW0G00 Brexanolone
-
XW0G00 Spesolimab Monoclonal Antibody
-
XW0G01 Daratumumab and Hyaluronidase-fihj
-
XW0G01 Eladocagene exuparvovec
-
XW0G02 Bromelain-enriched Proteolytic Enzyme
-
XW0G02 Nerinitide
-
XW0G03 Durvalumab Antineoplastic
-
XW0G03 Maribavir Anti-infective
-
XW0G04 Teclistamab Antineoplastic
-
XW0G05 Mosunetuzumab Antineoplastic
-
XW0G05 Narsoplimab Monoclonal Antibody
-
XW0G06 Afamitresgene Autoleucel Immunotherapy
-
XW0G06 Lefamulin Anti-infective
-
XW0G06 Terlipressin
-
XW0G07 Coagulation Factor Xa, Inactivated
-
XW0G07 Tabelecleucel Immunotherapy
-
XW0G07 Trilaciclib
-
XW0G08 Lurbinectedin
-
XW0G08 Mineral-based Topical Hemostatic Agent
-
XW0G08 Treosulfan
-
XW0G08 Uridine Triacetate
-
XW0G09 Ceftolozane/Tazobactam Anti-infective
-
XW0G09 Inebilizumab-cdon
-
XW0G09 Satralizumab-mwge
-
XW0G0A Cefiderocol Anti-infective
-
XW0G0A Ciltacabtagene Autoleucel
-
XW0G0B Amivantamab Monoclonal Antibody
-
XW0G0B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0G0B Omadacycline Anti-infective
-
XW0G0C Eculizumab
-
XW0G0C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0G0D Atezolizumab Antineoplastic
-
XW0G0D Engineered Allogeneic Thymus Tissue
-
XW0G0E Etesevimab Monoclonal Antibody
-
XW0G0E Remdesivir Anti-infective
-
XW0G0F Bamlanivimab Monoclonal Antibody
-
XW0G0F Other New Technology Therapeutic Substance
-
XW0G0G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0G0G Plazomicin Anti-infective
-
XW0G0G REGN-COV2 Monoclonal Antibody
-
XW0G0G Sarilumab
-
XW0G0H Axicabtagene Ciloleucel Immunotherapy
-
XW0G0H Other New Technology Monoclonal Antibody
-
XW0G0H Synthetic Human Angiotensin II
-
XW0G0H Tocilizumab
-
XW0G0J Apalutamide Antineoplastic
-
XW0G0J Tisagenlecleucel Immunotherapy
-
XW0G0K Fosfomycin Anti-infective
-
XW0G0K Idecabtagene Vicleucel Immunotherapy
-
XW0G0K Leronlimab Monoclonal Antibody
-
XW0G0L CD24Fc Immunomodulator
-
XW0G0L Erdafitinib Antineoplastic
-
XW0G0L Lifileucel Immunotherapy
-
XW0G0M Baricitinib
-
XW0G0M Brexucabtagene Autoleucel Immunotherapy
-
XW0G0M Esketamine Hydrochloride
-
XW0G0N Lisocabtagene Maraleucel Immunotherapy
-
XW0G0N Meropenem-vaborbactam Anti-infective
-
XW0G0P Antibiotic-eluting Bone Void Filler
-
XW0G0Q Tagraxofusp-erzs Antineoplastic
-
XW0G0R Fostamatinib
-
XW0G0R Venetoclax Antineoplastic
-
XW0G0S COVID-19 Vaccine Dose 1
-
XW0G0S Iobenguane I-131 Antineoplastic
-
XW0G0T COVID-19 Vaccine Dose 2
-
XW0G0T Ruxolitinib
-
XW0G0U COVID-19 Vaccine
-
XW0G0U Imipenem-cilastatin-relebactam Anti-infective
-
XW0G0V COVID-19 Vaccine Dose 3
-
XW0G0V Gilteritinib Antineoplastic
-
XW0G0W Caplacizumab
-
XW0G0W COVID-19 Vaccine Booster
-
XW0G0X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0G0X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0G0Y Other New Technology Monoclonal Antibody
-
-
XW0G3 Percutaneous
-
XW0G30 Brexanolone
-
XW0G30 Spesolimab Monoclonal Antibody
-
XW0G31 Daratumumab and Hyaluronidase-fihj
-
XW0G31 Eladocagene exuparvovec
-
XW0G32 Bromelain-enriched Proteolytic Enzyme
-
XW0G32 Nerinitide
-
XW0G33 Durvalumab Antineoplastic
-
XW0G33 Maribavir Anti-infective
-
XW0G34 Teclistamab Antineoplastic
-
XW0G35 Mosunetuzumab Antineoplastic
-
XW0G35 Narsoplimab Monoclonal Antibody
-
XW0G36 Afamitresgene Autoleucel Immunotherapy
-
XW0G36 Lefamulin Anti-infective
-
XW0G36 Terlipressin
-
XW0G37 Coagulation Factor Xa, Inactivated
-
XW0G37 Tabelecleucel Immunotherapy
-
XW0G37 Trilaciclib
-
XW0G38 Lurbinectedin
-
XW0G38 Mineral-based Topical Hemostatic Agent
-
XW0G38 Treosulfan
-
XW0G38 Uridine Triacetate
-
XW0G39 Ceftolozane/Tazobactam Anti-infective
-
XW0G39 Inebilizumab-cdon
-
XW0G39 Satralizumab-mwge
-
XW0G3A Cefiderocol Anti-infective
-
XW0G3A Ciltacabtagene Autoleucel
-
XW0G3B Amivantamab Monoclonal Antibody
-
XW0G3B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0G3B Omadacycline Anti-infective
-
XW0G3C Eculizumab
-
XW0G3C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0G3D Atezolizumab Antineoplastic
-
XW0G3D Engineered Allogeneic Thymus Tissue
-
XW0G3E Etesevimab Monoclonal Antibody
-
XW0G3E Remdesivir Anti-infective
-
XW0G3F Bamlanivimab Monoclonal Antibody
-
XW0G3F Other New Technology Therapeutic Substance
-
XW0G3G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0G3G Plazomicin Anti-infective
-
XW0G3G REGN-COV2 Monoclonal Antibody
-
XW0G3G Sarilumab
-
XW0G3H Axicabtagene Ciloleucel Immunotherapy
-
XW0G3H Other New Technology Monoclonal Antibody
-
XW0G3H Synthetic Human Angiotensin II
-
XW0G3H Tocilizumab
-
XW0G3J Apalutamide Antineoplastic
-
XW0G3J Tisagenlecleucel Immunotherapy
-
XW0G3K Fosfomycin Anti-infective
-
XW0G3K Idecabtagene Vicleucel Immunotherapy
-
XW0G3K Leronlimab Monoclonal Antibody
-
XW0G3L CD24Fc Immunomodulator
-
XW0G3L Erdafitinib Antineoplastic
-
XW0G3L Lifileucel Immunotherapy
-
XW0G3M Baricitinib
-
XW0G3M Brexucabtagene Autoleucel Immunotherapy
-
XW0G3M Esketamine Hydrochloride
-
XW0G3N Lisocabtagene Maraleucel Immunotherapy
-
XW0G3N Meropenem-vaborbactam Anti-infective
-
XW0G3P Antibiotic-eluting Bone Void Filler
-
XW0G3Q Tagraxofusp-erzs Antineoplastic
-
XW0G3R Fostamatinib
-
XW0G3R Venetoclax Antineoplastic
-
XW0G3S COVID-19 Vaccine Dose 1
-
XW0G3S Iobenguane I-131 Antineoplastic
-
XW0G3T COVID-19 Vaccine Dose 2
-
XW0G3T Ruxolitinib
-
XW0G3U COVID-19 Vaccine
-
XW0G3U Imipenem-cilastatin-relebactam Anti-infective
-
XW0G3V COVID-19 Vaccine Dose 3
-
XW0G3V Gilteritinib Antineoplastic
-
XW0G3W Caplacizumab
-
XW0G3W COVID-19 Vaccine Booster
-
XW0G3X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0G3X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0G3Y Other New Technology Monoclonal Antibody
-
-
XW0G7 Via Natural or Artificial Opening
-
XW0G70 Brexanolone
-
XW0G70 Spesolimab Monoclonal Antibody
-
XW0G71 Daratumumab and Hyaluronidase-fihj
-
XW0G71 Eladocagene exuparvovec
-
XW0G72 Bromelain-enriched Proteolytic Enzyme
-
XW0G72 Nerinitide
-
XW0G73 Durvalumab Antineoplastic
-
XW0G738Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
-
-
XW0G73 Maribavir Anti-infective
-
XW0G738Introduction of Maribavir Anti-infective into Upper GI, Via Natural or Artificial Opening, New Technology Group 8
-
-
XW0G74 Teclistamab Antineoplastic
-
XW0G75 Mosunetuzumab Antineoplastic
-
XW0G75 Narsoplimab Monoclonal Antibody
-
XW0G76 Afamitresgene Autoleucel Immunotherapy
-
XW0G76 Lefamulin Anti-infective
-
XW0G76 Terlipressin
-
XW0G77 Coagulation Factor Xa, Inactivated
-
XW0G77 Tabelecleucel Immunotherapy
-
XW0G77 Trilaciclib
-
XW0G78 Lurbinectedin
-
XW0G78 Mineral-based Topical Hemostatic Agent
-
XW0G78 Treosulfan
-
XW0G78 Uridine Triacetate
-
XW0G79 Ceftolozane/Tazobactam Anti-infective
-
XW0G79 Inebilizumab-cdon
-
XW0G79 Satralizumab-mwge
-
XW0G7A Cefiderocol Anti-infective
-
XW0G7A Ciltacabtagene Autoleucel
-
XW0G7B Amivantamab Monoclonal Antibody
-
XW0G7B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0G7B Omadacycline Anti-infective
-
XW0G7C Eculizumab
-
XW0G7C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0G7D Atezolizumab Antineoplastic
-
XW0G7D Engineered Allogeneic Thymus Tissue
-
XW0G7E Etesevimab Monoclonal Antibody
-
XW0G7E Remdesivir Anti-infective
-
XW0G7F Bamlanivimab Monoclonal Antibody
-
XW0G7F Other New Technology Therapeutic Substance
-
XW0G7G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0G7G Plazomicin Anti-infective
-
XW0G7G REGN-COV2 Monoclonal Antibody
-
XW0G7G Sarilumab
-
XW0G7H Axicabtagene Ciloleucel Immunotherapy
-
XW0G7H Other New Technology Monoclonal Antibody
-
XW0G7H Synthetic Human Angiotensin II
-
XW0G7H Tocilizumab
-
XW0G7J Apalutamide Antineoplastic
-
XW0G7J Tisagenlecleucel Immunotherapy
-
XW0G7K Fosfomycin Anti-infective
-
XW0G7K Idecabtagene Vicleucel Immunotherapy
-
XW0G7K Leronlimab Monoclonal Antibody
-
XW0G7L CD24Fc Immunomodulator
-
XW0G7L Erdafitinib Antineoplastic
-
XW0G7L Lifileucel Immunotherapy
-
XW0G7M Baricitinib
-
XW0G7M6Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6
-
-
XW0G7M Brexucabtagene Autoleucel Immunotherapy
-
XW0G7M6Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6
-
-
XW0G7M Esketamine Hydrochloride
-
XW0G7M6Introduction of Baricitinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 6
-
-
XW0G7N Lisocabtagene Maraleucel Immunotherapy
-
XW0G7N Meropenem-vaborbactam Anti-infective
-
XW0G7P Antibiotic-eluting Bone Void Filler
-
XW0G7Q Tagraxofusp-erzs Antineoplastic
-
XW0G7R Fostamatinib
-
XW0G7R7Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
-
-
XW0G7R Venetoclax Antineoplastic
-
XW0G7R7Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7
-
-
XW0G7S COVID-19 Vaccine Dose 1
-
XW0G7S Iobenguane I-131 Antineoplastic
-
XW0G7T COVID-19 Vaccine Dose 2
-
XW0G7T Ruxolitinib
-
XW0G7U COVID-19 Vaccine
-
XW0G7U Imipenem-cilastatin-relebactam Anti-infective
-
XW0G7V COVID-19 Vaccine Dose 3
-
XW0G7V Gilteritinib Antineoplastic
-
XW0G7W Caplacizumab
-
XW0G7W COVID-19 Vaccine Booster
-
XW0G7X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0G7X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0G7Y Other New Technology Monoclonal Antibody
-
-
XW0G8 Via Natural or Artificial Opening Endoscopic
-
XW0G80 Brexanolone
-
XW0G80 Spesolimab Monoclonal Antibody
-
XW0G81 Daratumumab and Hyaluronidase-fihj
-
XW0G81 Eladocagene exuparvovec
-
XW0G82 Bromelain-enriched Proteolytic Enzyme
-
XW0G82 Nerinitide
-
XW0G83 Durvalumab Antineoplastic
-
XW0G83 Maribavir Anti-infective
-
XW0G84 Teclistamab Antineoplastic
-
XW0G85 Mosunetuzumab Antineoplastic
-
XW0G85 Narsoplimab Monoclonal Antibody
-
XW0G86 Afamitresgene Autoleucel Immunotherapy
-
XW0G86 Lefamulin Anti-infective
-
XW0G86 Terlipressin
-
XW0G87 Coagulation Factor Xa, Inactivated
-
XW0G87 Tabelecleucel Immunotherapy
-
XW0G87 Trilaciclib
-
XW0G88 Lurbinectedin
-
XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
-
-
XW0G88 Mineral-based Topical Hemostatic Agent
-
XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
-
-
XW0G88 Treosulfan
-
XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
-
-
XW0G88 Uridine Triacetate
-
XW0G886Introduction of Mineral-based Topical Hemostatic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic, New Technology Group 6
-
-
XW0G89 Ceftolozane/Tazobactam Anti-infective
-
XW0G89 Inebilizumab-cdon
-
XW0G89 Satralizumab-mwge
-
XW0G8A Cefiderocol Anti-infective
-
XW0G8A Ciltacabtagene Autoleucel
-
XW0G8B Amivantamab Monoclonal Antibody
-
XW0G8B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0G8B Omadacycline Anti-infective
-
XW0G8C Eculizumab
-
XW0G8C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0G8D Atezolizumab Antineoplastic
-
XW0G8D Engineered Allogeneic Thymus Tissue
-
XW0G8E Etesevimab Monoclonal Antibody
-
XW0G8E Remdesivir Anti-infective
-
XW0G8F Bamlanivimab Monoclonal Antibody
-
XW0G8F Other New Technology Therapeutic Substance
-
XW0G8G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0G8G Plazomicin Anti-infective
-
XW0G8G REGN-COV2 Monoclonal Antibody
-
XW0G8G Sarilumab
-
XW0G8H Axicabtagene Ciloleucel Immunotherapy
-
XW0G8H Other New Technology Monoclonal Antibody
-
XW0G8H Synthetic Human Angiotensin II
-
XW0G8H Tocilizumab
-
XW0G8J Apalutamide Antineoplastic
-
XW0G8J Tisagenlecleucel Immunotherapy
-
XW0G8K Fosfomycin Anti-infective
-
XW0G8K Idecabtagene Vicleucel Immunotherapy
-
XW0G8K Leronlimab Monoclonal Antibody
-
XW0G8L CD24Fc Immunomodulator
-
XW0G8L Erdafitinib Antineoplastic
-
XW0G8L Lifileucel Immunotherapy
-
XW0G8M Baricitinib
-
XW0G8M Brexucabtagene Autoleucel Immunotherapy
-
XW0G8M Esketamine Hydrochloride
-
XW0G8N Lisocabtagene Maraleucel Immunotherapy
-
XW0G8N Meropenem-vaborbactam Anti-infective
-
XW0G8P Antibiotic-eluting Bone Void Filler
-
XW0G8Q Tagraxofusp-erzs Antineoplastic
-
XW0G8R Fostamatinib
-
XW0G8R Venetoclax Antineoplastic
-
XW0G8S COVID-19 Vaccine Dose 1
-
XW0G8S Iobenguane I-131 Antineoplastic
-
XW0G8T COVID-19 Vaccine Dose 2
-
XW0G8T Ruxolitinib
-
XW0G8U COVID-19 Vaccine
-
XW0G8U Imipenem-cilastatin-relebactam Anti-infective
-
XW0G8V COVID-19 Vaccine Dose 3
-
XW0G8V Gilteritinib Antineoplastic
-
XW0G8W Caplacizumab
-
XW0G8W COVID-19 Vaccine Booster
-
XW0G8X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0G8X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0G8Y Other New Technology Monoclonal Antibody
-
-
XW0GX External
-
XW0GX0 Brexanolone
-
XW0GX0 Spesolimab Monoclonal Antibody
-
XW0GX1 Daratumumab and Hyaluronidase-fihj
-
XW0GX1 Eladocagene exuparvovec
-
XW0GX2 Bromelain-enriched Proteolytic Enzyme
-
XW0GX2 Nerinitide
-
XW0GX3 Durvalumab Antineoplastic
-
XW0GX3 Maribavir Anti-infective
-
XW0GX4 Teclistamab Antineoplastic
-
XW0GX5 Mosunetuzumab Antineoplastic
-
XW0GX5 Narsoplimab Monoclonal Antibody
-
XW0GX6 Afamitresgene Autoleucel Immunotherapy
-
XW0GX6 Lefamulin Anti-infective
-
XW0GX6 Terlipressin
-
XW0GX7 Coagulation Factor Xa, Inactivated
-
XW0GX7 Tabelecleucel Immunotherapy
-
XW0GX7 Trilaciclib
-
XW0GX8 Lurbinectedin
-
XW0GX8 Mineral-based Topical Hemostatic Agent
-
XW0GX8 Treosulfan
-
XW0GX8 Uridine Triacetate
-
XW0GX9 Ceftolozane/Tazobactam Anti-infective
-
XW0GX9 Inebilizumab-cdon
-
XW0GX9 Satralizumab-mwge
-
XW0GXA Cefiderocol Anti-infective
-
XW0GXA Ciltacabtagene Autoleucel
-
XW0GXB Amivantamab Monoclonal Antibody
-
XW0GXB Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0GXB Omadacycline Anti-infective
-
XW0GXC Eculizumab
-
XW0GXC Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0GXD Atezolizumab Antineoplastic
-
XW0GXD Engineered Allogeneic Thymus Tissue
-
XW0GXE Etesevimab Monoclonal Antibody
-
XW0GXE Remdesivir Anti-infective
-
XW0GXF Bamlanivimab Monoclonal Antibody
-
XW0GXF Other New Technology Therapeutic Substance
-
XW0GXG Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0GXG Plazomicin Anti-infective
-
XW0GXG REGN-COV2 Monoclonal Antibody
-
XW0GXG Sarilumab
-
XW0GXH Axicabtagene Ciloleucel Immunotherapy
-
XW0GXH Other New Technology Monoclonal Antibody
-
XW0GXH Synthetic Human Angiotensin II
-
XW0GXH Tocilizumab
-
XW0GXJ Apalutamide Antineoplastic
-
XW0GXJ Tisagenlecleucel Immunotherapy
-
XW0GXK Fosfomycin Anti-infective
-
XW0GXK Idecabtagene Vicleucel Immunotherapy
-
XW0GXK Leronlimab Monoclonal Antibody
-
XW0GXL CD24Fc Immunomodulator
-
XW0GXL Erdafitinib Antineoplastic
-
XW0GXL Lifileucel Immunotherapy
-
XW0GXM Baricitinib
-
XW0GXM Brexucabtagene Autoleucel Immunotherapy
-
XW0GXM Esketamine Hydrochloride
-
XW0GXN Lisocabtagene Maraleucel Immunotherapy
-
XW0GXN Meropenem-vaborbactam Anti-infective
-
XW0GXP Antibiotic-eluting Bone Void Filler
-
XW0GXQ Tagraxofusp-erzs Antineoplastic
-
XW0GXR Fostamatinib
-
XW0GXR Venetoclax Antineoplastic
-
XW0GXS COVID-19 Vaccine Dose 1
-
XW0GXS Iobenguane I-131 Antineoplastic
-
XW0GXT COVID-19 Vaccine Dose 2
-
XW0GXT Ruxolitinib
-
XW0GXU COVID-19 Vaccine
-
XW0GXU Imipenem-cilastatin-relebactam Anti-infective
-
XW0GXV COVID-19 Vaccine Dose 3
-
XW0GXV Gilteritinib Antineoplastic
-
XW0GXW Caplacizumab
-
XW0GXW COVID-19 Vaccine Booster
-
XW0GXX Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0GXX Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0GXY Other New Technology Monoclonal Antibody
-
-